.png){kind=icon}
返回
Statins and Inflammation
.png){kind=icon}
PRE
AI
DOI：10.1007/s11883-021-00977-6.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Purpose of Review Chronic inflammation has been recognized as one of the most important pathophysiological mechanisms' initiation and progression of atherosclerosis. Statins belong to most successful therapeutic agents in the prevention and treatment of atherothrombotic vascular disease. Their non-lipid related effects including suppression of inflammation have been repeatedly proven in both experimental and clinical settings. Recent Findings Recently, the importance of inflammation in the process of atherosclerosis has been confirmed by interventions targeting inflammation selectively. Clinical trial with selective inhibitor of a principal inflammatory mediator interleukin 1-beta - canakinumab - confirmed the notion of direct vasculoprotective effects of primarily targeting inflammation. This has increased interest in the non-lipid, pleiotropic and, particularly, anti-inflammatory effects of statins. Summary Anti-inflammatory effects of statins have been proven both experimentally and in clinical settings beyond any doubt. They comprise a direct positive effect on not only many cell types and pathways that are lipid independent but, also, some that are mediated by lipid modification. Undoubtedly, suppression of inflammatory response by statins contributes to their generally positive action in atherosclerosis and represents an important part of the vasculo- and atheroprotective effect of this drug class.
Keyword:
Atherosclerosis
Cardiovascular
Statins
Inflammation
Pleiotropy
Biomarkers
Endothelial function
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
5.2
论文数:
1.5K
被引数:
4.5K
机构
引用论文
Chemokines - Key regulators of mononuclear cell recruitment in atherosclerotic vascular disease
PREAI
分享收藏Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitorsHMG CoA还原酶抑制剂上调内皮型一氧化氮合酶.png)
CIRCULATION
OAAI
CIRCULATIONIF38.6
OAAI分享收藏
查看更多内容